Copyright Reports & Markets. All rights reserved.

Global Oncology Based Molecular Diagnostic Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Oncology Based Molecular Diagnostic Revenue
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Oncology Based Molecular Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Instruments
      • 1.4.3 Reagents
    • 1.5 Market by Application
      • 1.5.1 Global Oncology Based Molecular Diagnostic Market Share by Application: 2020 VS 2026
      • 1.5.2 Breast Cancer
      • 1.5.3 Prostate Cancer
      • 1.5.4 Colorectal Cancer
      • 1.5.5 Cervical Cancer
      • 1.5.6 Liver Cancer
      • 1.5.7 Lung Cancer
      • 1.5.8 Blood Cancer
      • 1.5.9 Kidney Cancer
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends by Regions

    • 2.1 Oncology Based Molecular Diagnostic Market Perspective (2015-2026)
    • 2.2 Oncology Based Molecular Diagnostic Growth Trends by Regions
      • 2.2.1 Oncology Based Molecular Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Oncology Based Molecular Diagnostic Historic Market Share by Regions (2015-2020)
      • 2.2.3 Oncology Based Molecular Diagnostic Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Oncology Based Molecular Diagnostic Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Oncology Based Molecular Diagnostic Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Oncology Based Molecular Diagnostic Players by Market Size
      • 3.1.1 Global Top Oncology Based Molecular Diagnostic Players by Revenue (2015-2020)
      • 3.1.2 Global Oncology Based Molecular Diagnostic Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Oncology Based Molecular Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Oncology Based Molecular Diagnostic Market Concentration Ratio
      • 3.2.1 Global Oncology Based Molecular Diagnostic Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Oncology Based Molecular Diagnostic Revenue in 2019
    • 3.3 Oncology Based Molecular Diagnostic Key Players Head office and Area Served
    • 3.4 Key Players Oncology Based Molecular Diagnostic Product Solution and Service
    • 3.5 Date of Enter into Oncology Based Molecular Diagnostic Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2015-2026)

    • 4.1 Global Oncology Based Molecular Diagnostic Historic Market Size by Type (2015-2020)
    • 4.2 Global Oncology Based Molecular Diagnostic Forecasted Market Size by Type (2021-2026)

    5 Oncology Based Molecular Diagnostic Breakdown Data by Application (2015-2026)

    • 5.1 Global Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)
    • 5.2 Global Oncology Based Molecular Diagnostic Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Oncology Based Molecular Diagnostic Market Size (2015-2020)
    • 6.2 Oncology Based Molecular Diagnostic Key Players in North America (2019-2020)
    • 6.3 North America Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
    • 6.4 North America Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Oncology Based Molecular Diagnostic Market Size (2015-2020)
    • 7.2 Oncology Based Molecular Diagnostic Key Players in Europe (2019-2020)
    • 7.3 Europe Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
    • 7.4 Europe Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)

    8 China

    • 8.1 China Oncology Based Molecular Diagnostic Market Size (2015-2020)
    • 8.2 Oncology Based Molecular Diagnostic Key Players in China (2019-2020)
    • 8.3 China Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
    • 8.4 China Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Oncology Based Molecular Diagnostic Market Size (2015-2020)
    • 9.2 Oncology Based Molecular Diagnostic Key Players in Japan (2019-2020)
    • 9.3 Japan Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
    • 9.4 Japan Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Oncology Based Molecular Diagnostic Market Size (2015-2020)
    • 10.2 Oncology Based Molecular Diagnostic Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)

    11 India

    • 11.1 India Oncology Based Molecular Diagnostic Market Size (2015-2020)
    • 11.2 Oncology Based Molecular Diagnostic Key Players in India (2019-2020)
    • 11.3 India Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
    • 11.4 India Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Oncology Based Molecular Diagnostic Market Size (2015-2020)
    • 12.2 Oncology Based Molecular Diagnostic Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Oncology Based Molecular Diagnostic Market Size by Type (2015-2020)
    • 12.4 Central & South America Oncology Based Molecular Diagnostic Market Size by Application (2015-2020)

    13 Key Players Profiles

    • 13.1 Abbott Laboratories
      • 13.1.1 Abbott Laboratories Company Details
      • 13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
      • 13.1.3 Abbott Laboratories Oncology Based Molecular Diagnostic Introduction
      • 13.1.4 Abbott Laboratories Revenue in Oncology Based Molecular Diagnostic Business (2015-2020))
      • 13.1.5 Abbott Laboratories Recent Development
    • 13.2 Bayer Healthcare
      • 13.2.1 Bayer Healthcare Company Details
      • 13.2.2 Bayer Healthcare Business Overview and Its Total Revenue
      • 13.2.3 Bayer Healthcare Oncology Based Molecular Diagnostic Introduction
      • 13.2.4 Bayer Healthcare Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
      • 13.2.5 Bayer Healthcare Recent Development
    • 13.3 Beckton Dickinson
      • 13.3.1 Beckton Dickinson Company Details
      • 13.3.2 Beckton Dickinson Business Overview and Its Total Revenue
      • 13.3.3 Beckton Dickinson Oncology Based Molecular Diagnostic Introduction
      • 13.3.4 Beckton Dickinson Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
      • 13.3.5 Beckton Dickinson Recent Development
    • 13.4 Cepheid
      • 13.4.1 Cepheid Company Details
      • 13.4.2 Cepheid Business Overview and Its Total Revenue
      • 13.4.3 Cepheid Oncology Based Molecular Diagnostic Introduction
      • 13.4.4 Cepheid Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
      • 13.4.5 Cepheid Recent Development
    • 13.5 Dako
      • 13.5.1 Dako Company Details
      • 13.5.2 Dako Business Overview and Its Total Revenue
      • 13.5.3 Dako Oncology Based Molecular Diagnostic Introduction
      • 13.5.4 Dako Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
      • 13.5.5 Dako Recent Development
    • 13.6 Danaher Corporation
      • 13.6.1 Danaher Corporation Company Details
      • 13.6.2 Danaher Corporation Business Overview and Its Total Revenue
      • 13.6.3 Danaher Corporation Oncology Based Molecular Diagnostic Introduction
      • 13.6.4 Danaher Corporation Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
      • 13.6.5 Danaher Corporation Recent Development
    • 13.7 Gen Probe
      • 13.7.1 Gen Probe Company Details
      • 13.7.2 Gen Probe Business Overview and Its Total Revenue
      • 13.7.3 Gen Probe Oncology Based Molecular Diagnostic Introduction
      • 13.7.4 Gen Probe Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
      • 13.7.5 Gen Probe Recent Development
    • 13.8 Qiagen
      • 13.8.1 Qiagen Company Details
      • 13.8.2 Qiagen Business Overview and Its Total Revenue
      • 13.8.3 Qiagen Oncology Based Molecular Diagnostic Introduction
      • 13.8.4 Qiagen Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
      • 13.8.5 Qiagen Recent Development
    • 13.9 Roche Diagnostics
      • 13.9.1 Roche Diagnostics Company Details
      • 13.9.2 Roche Diagnostics Business Overview and Its Total Revenue
      • 13.9.3 Roche Diagnostics Oncology Based Molecular Diagnostic Introduction
      • 13.9.4 Roche Diagnostics Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
      • 13.9.5 Roche Diagnostics Recent Development
    • 13.10 Siemens Healthineers
      • 13.10.1 Siemens Healthineers Company Details
      • 13.10.2 Siemens Healthineers Business Overview and Its Total Revenue
      • 13.10.3 Siemens Healthineers Oncology Based Molecular Diagnostic Introduction
      • 13.10.4 Siemens Healthineers Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
      • 13.10.5 Siemens Healthineers Recent Development
    • 13.11 Sysmex Corporation
      • 10.11.1 Sysmex Corporation Company Details
      • 10.11.2 Sysmex Corporation Business Overview and Its Total Revenue
      • 10.11.3 Sysmex Corporation Oncology Based Molecular Diagnostic Introduction
      • 10.11.4 Sysmex Corporation Revenue in Oncology Based Molecular Diagnostic Business (2015-2020)
      • 10.11.5 Sysmex Corporation Recent Development

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      This report focuses on the global Oncology Based Molecular Diagnostic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncology Based Molecular Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Abbott Laboratories
      Bayer Healthcare
      Beckton Dickinson
      Cepheid
      Dako
      Danaher Corporation
      Gen Probe
      Qiagen
      Roche Diagnostics
      Siemens Healthineers
      Sysmex Corporation

      Market segment by Type, the product can be split into
      Instruments
      Reagents
      Market segment by Application, split into
      Breast Cancer
      Prostate Cancer
      Colorectal Cancer
      Cervical Cancer
      Liver Cancer
      Lung Cancer
      Blood Cancer
      Kidney Cancer

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Oncology Based Molecular Diagnostic status, future forecast, growth opportunity, key market and key players.
      To present the Oncology Based Molecular Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by type, market and key regions.

      In this study, the years considered to estimate the market size of Oncology Based Molecular Diagnostic are as follows:
      History Year: 2015-2019
      Base Year: 2019
      Estimated Year: 2020
      Forecast Year 2020 to 2026
      For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now